Compute Health Wants to Amend Their Warrant Agreement
by Kristi Marvin on 2023-07-10 at 7:36pm

Compute Health Acquisition Corp (NYSE: CPUH), recently amended their completion proxy outlining some big changes to their warrants as part of the closing of their business combination with Allurion. Let’s unpack the details.

What’s Changing

In simple terms, Compute Health proposes four main changes to its warrant agreement:

  1. Eliminate of section 4.5 from the original warrant agreement, which provides for the adjustment of the number of shares that a warrant holder receives in case of reorganizations, mergers, or certain other events involving Compute Health, i.e., the “anti-dilution” provision.
  2. Following a Business Combination, each existing warrant will be adjusted to allow the holder to purchase 1.420455 shares of the newly formed company, New Allurion, at the same exercise price of $11.50 per share. Previously, each warrant entitled the holder to purchase one share of Compute Health.
  3. Each holder of Compute Health public warrants will receive half of a New Allurion public warrant for each Compute Health public warrant they hold after the Business Combination.
  4. Extend the term of the Compute Health Warrants to expire six years after the completion of the Business Combination.

Impact on Warrant Holders

The critical question here is: are these changes good or bad for warrant holders?

First, let’s look at the change to the number of shares per warrant. On the surface, it might appear more attractive as each warrant now allows for the purchase of more shares in the new company than before. Instead of exercising one full warrant to purchase one full share, warrant holders would be exercising one full warrant to purchase 1.420455 shares. However, post closing, Compute Health public warrants holders will receive only half of a New Allurion public warrant.

As a result, if you’re a Compute Health warrant holder, in actuality you will be exercising one whole warrant to receive only 0.7102275 shares.

So, if we try to calculate how these changes differ in value, and whereas before the threshold was an $11.50 exercise price, technically, it is now equivalent to $16.19 (if you divide $11.50 by 0.7102275, instead of one warrant).

However, it appears Compute Health and Allurion are compensating for that by adding an extra year to the term of the warrants to provide additional value. Where previously the public warrants had a term of five years, they will now have six years.

Regardless, the item that is going to be of most interest to warrant holders is the elimination of section 4.5 in the original warrant agreement – the anti-dilution provisions. It raises the question as to why does Compute Health and Allurion want to eliminate this?  Are they planning another acquisition or some type of scenario where warrant holders would be disadvantaged without section 4.5? Keep in mind that the warrant proposal requires the approval of at least 50% of holders and section 4.5 is exactly the type of amendment that makes warrant holders itchy to vote no.

 

Recent Posts
by Nicholas Alan Clayton on 2025-02-13 at 8:19am

At the SPAC of Dawn  The sudden burst of SPAC activity this week slowed down after the closing bell yesterday as the market faces a period sandwiched between CPI and PPI readouts. Yesterday’s CPI news and Fed Chair Jerome Powell’s comments before Congress did not provide an instant relief in terms of clarity on a...

by Kristi Marvin on 2025-02-12 at 5:34pm

Maywood Acquisition Corp. (NASDAQ:MAYAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MAYAU”, Thursday, February 13, 2025. Maywood will have a broad search focus and will pursue an initial business combination in any industry or geographic location. The team is led...

by Nicholas Alan Clayton on 2025-02-12 at 5:20pm

Artius II Acquisition Inc. (NASDAQ:AACBU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “AACBU”, Thursday, February 13, 2025. Artius II intends to search for a target company with a technology-enabled business with opportunities that have multiple vectors to create value post-combination....

by Kristi Marvin on 2025-02-12 at 5:08pm

It’s been an active week for Cohen & Company having filed four new SPACs in less than a week. Crane Harbor Acquisition Corp. (NASDAQ:CHACU) is the latest Cohen IPO filing and shows the former Osprey team as sponsors. Name changes for teams have been a trend for the past year or so and feels a...

by Nicholas Alan Clayton on 2025-02-12 at 2:42pm

Harvard Ave Acquisition Corporation (NASDAQ:HAVAU) has filed for a $250 million SPAC in a deal that significantly nudges upwards the prominence of D. Boral in the 2025 SPAC market to-date. Early 2025 filing activity has brought out some of the most biggest underwriters in SPACs, but, with Harvard Ave, the title of largest proposed SPAC...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved